Table S1.
Formulation | Drug/phosphatidylcholine (%, w/w, A) |
Cholesterol (%, w/v, B) |
Sonication time (minutes, C) |
---|---|---|---|
NLA1 | 10 | 0.1 | 3 |
NLA2 | 20 | 0.1 | 3 |
NLA3 | 10 | 0.3 | 3 |
NLA4 | 20 | 0.3 | 3 |
NLA5 | 10 | 0.2 | 2 |
NLA6 | 20 | 0.2 | 2 |
NLA7 | 10 | 0.2 | 4 |
NLA8 | 20 | 0.2 | 4 |
NLA9 | 15 | 0.1 | 2 |
NLA10 | 15 | 0.3 | 2 |
NLA11 | 15 | 0.1 | 4 |
NLA12 | 15 | 0.3 | 4 |
NLA13 | 15 | 0.2 | 3 |
NLA14 | 15 | 0.2 | 3 |
NLA15 | 15 | 0.2 | 3 |
NLA16 | 15 | 0.2 | 3 |
NLA17 | 15 | 0.2 | 3 |
Abbreviation: NLA, nanoliposomal artemisinin.